E-LIB Suche - Ergebnisse für: Guida, A

1

OC.05.6: TARGETING RUVBL1 REDUCES MTOR-DRIVEN NASH-HCC DEVE..:

Guida, A. ; Simeone, I. ; Papini, D....
Digestive and Liver Disease. 56 (2024) - p. S153 , 2024

Link: https://doi.org/10.1016/..

2

Dystrophie Musculaire de Duchenne: Aspects cliniques, biolo..:

Ibrahim Sory, P ; Sidi, T ; Guida, L...
Rhumatologie Africaine Francophone. 6 (2024) 2 - p. 18-23 , 2024

Link: https://doi.org/10.62455..

3

Targeting RuvBL1 reduces mTOR-driven NASH-HCC progression i..:

Guida, A. ; Simeone, I. ; Papini, D....
Digestive and Liver Disease. 56 (2024) - p. S96 , 2024

Link: https://doi.org/10.1016/..

4

154P Five-year survival and safety outcomes from the START-..:

Arcidiacono, F. ; Anselmo, P. ; Casale, M....
ESMO Open. 9 (2024) - p. 102909 , 2024

Link: https://doi.org/10.1016/..

5

RUVBL1 correlates with chaperones expression in HCC and its..:

Mello, T. ; Guida, A. ; Simeone, I....
Digestive and Liver Disease. 56 (2024) - p. S97 , 2024

Link: https://doi.org/10.1016/..

6

RuvBL1 ATPase activity is essential for mitochondrial integ..:

Simeone, I. ; Guida, A. ; Polvani, S....
Digestive and Liver Disease. 55 (2023) - p. S58-S59 , 2023

Link: https://doi.org/10.1016/..

7

128P Stereotactic ablative radiotherapy in locally-advanced..:

Arcidiacono, F. ; Casale, M. ; Maranzano, E....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S113 , 2023

Link: https://doi.org/10.1016/..

8

OC-0763 SAbR in LA-NSCLC patients unfit for concurrent ChT-..:

Arcidiacono, F. ; Anselmo, P. ; Casale, M....
Radiotherapy and Oncology. 182 (2023) - p. S629 , 2023

Link: https://doi.org/10.1016/..

9

European Association for Endoscopic Surgery (EAES) consensu..:

Cassinotti, E. ; Al-Taher, M. ; Antoniou, S. A....
Surgical Endoscopy. 37 (2023) 3 - p. 1629-1648 , 2023

Link: https://doi.org/10.1007/..

10

EP11.01-01 Final Analysis of First-Line Chemo-Immunotherapy..:

Leonetti, A. ; Perrone, F. ; Puntoni, M....
Journal of Thoracic Oncology. 18 (2023) 11 - p. S610 , 2023

Link: https://doi.org/10.1016/..

11

126P Chemotherapy and stereotactic ablative radiotherapy in..:

Arcidiacono, F. ; Anselmo, P. ; Casale, M....
Journal of Thoracic Oncology. 18 (2023) 4 - p. S112 , 2023

Link: https://doi.org/10.1016/..

12

RuvBL1 haploinsufficiency promotes hepatic lipid catabolism..:

Guida, A. ; Simeone, I. ; Polvani, S....
Digestive and Liver Disease. 55 (2023) - p. S55-S56 , 2023

Link: https://doi.org/10.1016/..

13

PB0989 The Efficacy and Safety of Direct Oral Anticoagulant..:

Madonna, P. ; Guida, A. ; Mocerino, L....
Research and Practice in Thrombosis and Haemostasis. 7 (2023) - p. 101800 , 2023

Link: https://doi.org/10.1016/..

14

Targeting the AAA+ ATPase RuvBL1 reduces mTOR-driven NASH-H..:

Guida, A. ; Simeone, I. ; Papini, D....
Digestive and Liver Disease. 55 (2023) - p. S225 , 2023

Link: https://doi.org/10.1016/..

15

T.03.4 SPHINGOSINES, COUP-TFII AND PANCREATIC CANCER:

Polvani, S. ; Mello, T. ; Ceni, E....
Digestive and Liver Disease. 55 (2023) - p. S146 , 2023

Link: https://doi.org/10.1016/..